Cassava Sciences reported $-44220000 in Net Income for its fiscal quarter ending in June of 2025.


Net Income Change Date
Abbott USD 1.78B 454M Jun/2025
Amgen USD 1.43B 298M Jun/2025
Biogen USD 634.8M 394.3M Jun/2025
Cassava Sciences USD -44220000 16.62M Jun/2025
Eisai JPY 14.47B 13.52B Jun/2025
Eli Lilly USD 5.66B 2.9B Jun/2025
Geron USD -16375000 3.46M Jun/2025
J&J USD 5.54B 5.46B Jun/2025
Merck USD 4.43B 652M Jun/2025
Novartis USD 4.02B 418M Jun/2025
Pfizer USD 2.91B 58M Jun/2025
Roche Holding CHF 1.01B 2.12B Dec/2024